Elevation Oncology
Stock Forecast, Prediction & Price Target
Elevation Oncology Financial Estimates
Elevation Oncology Revenue Estimates
Elevation Oncology EBITDA Estimates
Elevation Oncology Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $16.24M Low: $16.24M High: $16.24M avg. 0% | Avg: $88.57M Low: $88.57M High: $88.57M avg. 445.09% |
Net Income
% change YoY
| $-32.03M N/A | $-95.08M -196.76% | $-45.70M 51.93% | Avg: $-62.20M Low: $-44.98M High: $-25.55M avg. -36.09% | Avg: $-81.94M Low: $-61.33M High: $-21.46M avg. -31.73% | Avg: $-41.29M Low: $-41.29M High: $-41.29M avg. 49.60% | Avg: $-18.26M Low: $-18.26M High: $-18.26M avg. 55.76% |
EBITDA
% change YoY
| $-32.02M N/A | $-94.54M -195.20% | $-41.46M 56.14% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.38 N/A | -$4.09 -196.37% | -$1.34 67.23% | Avg: -$0.98 Low: -$1.32 High: -$0.75 avg. 26.97% | Avg: -$1.12 Low: -$1.8 High: -$0.63 avg. -14.79% | Avg: -$1.21 Low: -$1.21 High: -$1.21 avg. -7.86% | Avg: -$0.54 Low: -$0.54 High: -$0.54 avg. 55.76% |
Operating Expenses
% change YoY
| $32.04M N/A | $94.54M 195.04% | $45.44M -51.93% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Elevation Oncology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 9.38% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -44.98M, average is -62.20M and high is -25.55M.
What is Elevation Oncology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 111.27% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Elevation Oncology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 15.01% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$1.32, average is -$0.98 and high is $-0.75.
What is the best performing analyst?
In the last twelve months analysts have been covering Elevation Oncology stock. The most successful analyst is Biren Amin.